Material-induced up-regulation of leukocyte CD11b during whole blood contact: Material differences and a role for complement

Journal of Biomedical Materials Research

Volumn 32, Issue 1, 1996, Pages 29-35

  Gemmell, Cynthia H ^a,c   Black, John P ^b   Yeo, Erik L ^a   Sefton, Michael V ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; BIOCOMPATIBILITY; BLOOD; CELLS; CHEMICAL ACTIVATION; HEMODYNAMICS; HYDROGELS; INTERFACES (MATERIALS); POLYETHYLENES; POLYVINYL ALCOHOLS;

CYTOMETRIC IMMUNOASSAYS; LEUKOCYTE ACTIVATION; MATERIAL INDUCED THROMBOGENICITY;

BIOMATERIALS;

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE;

ARTICLE; BLOOD COMPATIBILITY; CYTOMETRY; HYDROGEL; IMMUNOASSAY; LEUKOCYTE ACTIVATION; PROSTHESIS MATERIAL; RISK ASSESSMENT; THROMBOCYTE FUNCTION; THROMBOEMBOLISM; THROMBOGENICITY; THROMBOSIS;

ANTIGENS, CD11; BIOCOMPATIBLE MATERIALS; BIOPROSTHESIS; HUMANS; LEUKOCYTES; UP-REGULATION;

EID: 0030247222     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(199609)32:1<29::AID-JBM4>3.0.CO;2-R     Document Type: Article

References (35)

1. P. R. Craddock, J. Fehr, A. P. Dalmasso, K. L. Brighan, and H. S. Jacob, "Hemodialysis leukopenia; Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes," J. Clin. Invest., 59, 879-888 (1977).
2. D. E. Hammerschmidt, D. F. Stronced, T. K. Bowers, C. J. Lammi-Keefe, D. M. Kurth, A. Ozalins, D. M. Nicoloff, R. C. Lillehei, P. R. Craddock, and H. S. Jacob, "Complement activation and neutropenia occurring during cardiopulmonary bypass," J. Thorac. Cardiovasc. Surg., 81, 370-377 (1981).
3. J. Bohler, P. Kramer, O. Gotze, P. Schartz, and F. Scheler, "Leukocyte counts and complement activation during pump-driven and arteriovenous haemofiltration," Cont. Hephrol., 36, 15-17 (1983).
4. P. Ryhanen, E. Herva, A. Hollman, L. Nuutinen, R. Pihlajaniemi, and E. Saarela, "Changes in peripheral blood leukocyte counts, lymphocyte subpopulations and in vitro transformation after heart valve replacement," J. Thorac. Cardiovasc. Surg., 77, 259-265 (1979).
5. A. D. Shepard, J. A. Gelfand, A. D. Callow, and T. F. O'Donnell, "Complement activation by synthetic vascular prostheses," J. Vasc. Surg., 1, 829-838 (1984).
6. S. R. Hanson, "Device thrombosis and thromboembolism," Cardiovasc. Pathol., 2 (3, Suppl.) 157S-165S (1993).
7. T. A. Springer, "Adhesion receptors of the immune system," Nature, 346, 425-433 (1990).
8. D. C. Anderson, K. L. B. Freeman, B. Heerdt, B. J. Hughes, R. M. Jack, and C. W. Smith, "Abnormal stimulated adherence of neonatal granulocytes: Impaired induction of surface Mac-1 by chemotactic factors of secretagogues," Blood, 70, 740-750 (1987).
9. M. A. Arnaout, "Structure and function of the leukocyte adhesion molecules Cd11b/CD18," Blood, 75, 1037-1050 (1990).
10. T. K. Kishimoto, M. A. Jutila, E.L. Berg, and E. C. Butcher, "Neurophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors," Science, 245, 1238-1241 (1989).
11. MEL-14) induced by activators of protein kinase C: Receptor shedding due to accelerated proteolytic cleavage at the cell surface," J. Immunol., 144, 3130-3136 (1990).
12. M. Berger, B. Broxup, and M. V. Sefton, "Using ELISA to evaluate complement activation by reference biomaterials," J. Mater. Sci. Mater. in Med. 5, 622-627 (1994).
13. R. Deppisch, V. Schmitt, J. Bommer, G. M. Hansch, E. Ritz, and E. W. Rauterberg, "Fluid phase generation of terminal complement complex as a novel index of bioincompatibility," Kidney Int. 37, 696-706 (1990).
14. A-C. Hauser, K. Derfler, F. Stockenhuber, O. Janata, and P. Balcke, "Generation of the membrane attack complex during hemodialysis: Impact of classical and alternative pathway components," Clin. Sci. 79, 471-476 (1990).
15. C. H. Gemmell, S. M. Ramires, E. L. Yeo, and M. V. Sefton, "A flow cytometric immunoassay for assessment of platelet activation by artificial surfaces: identification of platelet-derived microparticles as a materials induced activation event," J. Lab. Clin. Med., 125, 276-287 (1995).
16. H. F. Weisman, T. Bartow, M. K. Leppo, H. C. Marsh, Jr., G. R. Carson, M. F. Concino, M. P. Boyle, K. H. Roux, M. L. Weisfeldt, and D. T. Fearon, "Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing postischemic myocardial inflammation and necrosis," Science, 249, 146-151 (1990).
17. C. H. Cholakis, W. Zingg, and M. V. Sefton, "Effect of heparin-PVA hydrogel on platelets in a chronic canine AV shunt" J. Biomed. Mater. Res., 23, 417-441 (1989).
18. B. Jakubiec, R. Roy, M. B. Isles, Y. Marois, and R. Guidoin, "Measurement of CD11/CD18 integrin expression on the polymorphonuclear cell surface after incubation with synthetic vascular prostheses," Am. Soc. Artif. Intern. Ors. J., 40, M616-M618 (1994).
19. F. Lim and S. L. Cooper, "The effect of surface hydrophilicity on biomaterial-leukocyte interactions," Am. Soc. Artif. Intern. Ors. Trans., 37, M146-M147 (1991).
20. A. Shanbhag, J. Yang, J. Lilien, and J. Black, "Decreased neutorphil respiratory burst on exposure to cobalt-chrome alloy and polystyrene in vitro," J. Biomed. Mater. Res., 26, 185-195 (1992).
21. S. S. Kaplan, R. E. Basford, E. Mora, M. H. Jeong, and R. L. Simmons, "Biomaterial-induced alterations of neutrophil superoxide production," J. Biomed. Mater. Res., 26, 1039-1051 (1992).
22. S. S. Kaplan, R. E. Basford, M. H. Jeong, and R. L. Simmons, "Mechanisms of biomaterial-induced superoxide release by neutrophils," J. Biomed. Mater. Res., 28, 377-386 (1994).
23. N. Rebuck and A. Finn, "Polymorphonuclear granulocyte expression of CD11a/CD18, CD11b/CD18, and L-selectin in normal individuals," FEMS Immunol. Med. Microbiol. 8, 189-196 (1994).
24. M. D. Kazatchkine, D. T. Fearon, D. D. Metcalfe, R. D. Rosenberg, and K. F. Austen, "Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase," J. Clin. Invest., 67, 223-228 (1981).
25. C. Combe, M. Pourtein, V. Precigout, A. Baquey, D. Morel, L. Potaux, P. Vincendeau, J. H. Bezian, and M. Aparicio, "Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high-flux biocompatible membrane," Am. J. Kidney Dis. 24, 437-442 (1994).
26. G. A. Herzlinger and R. D. Cumming, "Role of complement activation in cell adhesion to polymer blood contact surfaces," Am. Soc. Artif. Intern. Ors. Trans., 26, 165-171 (1980).
27. A. K. McNally and J. M. Anderson, "Complement C3 participation in monocyte adhesion to different surfaces," Proc. Natl. Acad. Sci., USA, 91, 10119-10123 (1994).
28. A. M. Gillinov, J. M. Redmond, J. A. Winkelstein, K. J. Zehr, A. Herskowitz, W. A. Baumgartner, and D. E. Cameron, "Complement and neutrophil activation during caridopulmonary bypass: A study in the complement-deficient dog," Ann. Thorac. Surg., 57, 345-352 (1994).
29. C. W. Smith, T. K. Kishimoto, O. Abbass, B. Hughes, R. Rothlein, L. V. McIntire, E. Butcher, and D. C. Anderson, "Chemotactic factors regulate lectin adhesion molecule 1 (LECAM-1) dependent neutrophil adhesion to cytokine stimulated endothelial cells in vitro," J. Clin. Invest. 87, 609-618 (1991).
30. A. Finn, N. Moat, N. Rebuck, N. Klein, S. Strobel, and M. Elliott, "Changes in neutrophil CD11b/CD18 and L-selectin expression and release of interleukin 8 and elastase in pediatric cardiopulmonary bypass," Agents Actions, 38, C44-C46 (1993).
31. R. A. Vertrees, W. Tao, G. C. Kramer, L. Nutt, L. B. McDaniel, S. D. DeVine, G. Jesmok, and J. B. Zwichenberger, "Tumor necrosis factor monoclonal antibody prevents alterations in leukocyte populations during cardiopulmonary bypass," Am. Soc. Artif. Intern. Ors. J., 40, M554-M559 (1994).
32. T. W. Muhlfilder, J. Niemetz, D. Kleutzer, D. Beebe, P A. Ward, and S. I. Rosenfeld, "C5 chemotactic fragment induces leukocyte production of tissue factor activity. A link between complement and coagulation," J. Clin. Invest., 63, 147-150 (1979).
33. D. S. Fair, J. S. Sundsmo, B. S. Schwartz, T. S. Edgington, and H. J. Muller-Eberhard, "Prothrombin activation by Factor B(Bb) of the alternative pathway of complement," Thromb Haemostas., 46, 301 (1981).
34. K. Von Appen, C. Goolsby, P. Mehl, R. Goewert, and P. Ivanovich, "Leukocyte adhesion molecules as biocompatibility markers for hemodialysis membranes", Am. Soc. Artif. Intern. Ors. J., 40, M609-M615 (1994).
35. C. H. Cholakis, W. Zingg, and M. V. Sefton, "Effect of heparin-PVA hydrogel on platelets in a chronic canine arterio-venous shunt," J. Biomed. Mater. Res., 23, 417-441 (1989).